Hiwemed
Latest round
- Series B
Last raised
- Jan 2025
Total raised
- Undisclosed
Investors
- 5
About Hiwemed
Based in Suzhou, China, and established in 2021, Hiwemed is a medical device company that focuses on the R&D of blood interventional embolization products. It cooperated with medical institutions such as Sun Yat-sen University Cancer Hospital, Shandong Province Tumor Hospital, and Wuhan Union Medical College Hospital. The company has 11 invention patents. The company's self-developed HiFlamingo® balloon occlusion catheter obtained marketing authorization from NMPA in April 2024. The company provides blood vessel interventional embolization products based on biomaterials research and development. It has planned 10 types of class III medical device products. Products within include microcatheter, hydrogel microspheres, slow-release microspheres, drug-carrying embolic microspheres, and medical microspheres. The microspheres can piggyback chemotherapy drugs that enable chemotherapy drugs to work inside the tumor, as well as embolize tumor vessels. Products can be used in vascular intervention, luminal intervention, tissue intervention, and tumor intervention. Hiwemed generates revenue by providing vascular intervention products and related services to hospitals and medical institutions.
Who invested in Hiwemed
5 investors across 2 rounds
See all investors in Hiwemed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hiwemed
Who invested in Hiwemed?
Hiwemed has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hiwemed raised?
Hiwemed has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Hiwemed last raise money?
Hiwemed's most recent round on record is a Series B, in Jan 2025.
What does Hiwemed do?
Based in Suzhou, China, and established in 2021, Hiwemed is a medical device company that focuses on the R&D of blood interventional embolization products.
Where is Hiwemed headquartered?
Hiwemed is headquartered in Suzhou, China.
Which VCs invest in companies like Hiwemed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Hiwemed's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Hiwemed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.